Article
Cannabinoid CB2 receptor orthologues; in vitro function and perspectives for preclinical to clinical translation
24 Jun 2023
Abstract excerpt
Abstract Cannabinoid CB2 receptor agonists are in development as therapeutic agents, including for immune modulation and pain relief. Despite promising results in rodent preclinical studies, efficacy in human clinical trials has been marginal to date. Fundamental differences in ligand engagement and signalling responses between the human CB2 receptor and preclinical model species orthologues may contribute to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
